Most validation dashboards measure how busy the team is. Documents produced, tests executed, protocols approved, days elapsed. All easy to count, and none of them answers the question management is actually asking: is this working?
Worse, activity metrics quietly reward the wrong behaviour. If you measure documents produced, you will get documents.
Measures that tell you something
- Defects found before go-live vs after. The single most useful ratio you can track. Validation exists to find problems early; this measures whether it does. A rising share found after go-live is a real signal, whatever the document count says.
- Where defects were found. Requirements, configuration, or testing? Defects traced back to unclear requirements tell you the problem is upstream of validation entirely.
- Rework rate on deliverables. How often documents go back after review. Persistent rework usually means template or training problems, not careless authors.
- Time from request to validated go-live, split into waiting time and working time. Most validation timelines are dominated by waiting, and nobody notices because the total is reported as one number.
- Periodic reviews completed on schedule. An unglamorous number that predicts inspection outcomes better than almost anything else.
- Findings from your own internal audits versus external ones. If external inspections find things your internal audits never do, your internal audit is the thing to fix.
Measures that mislead
Number of test cases executed. Rewards volume. Under CSA a good package may have fewer, better-targeted tests — so this number going down can mean things improved.
Pages of documentation. Actively harmful. It is the metric that produced the packages CSA exists to correct.
First-time-right approval rate. Sounds healthy, but push it hard and reviewers stop raising things. A review process that never changes anything is not a review process.
Zero deviations during testing. Often means testing was too gentle. Deviations found in testing are the system working.
Average validation duration alone. Without risk mix it compares nothing: a quarter with three Category 5 systems is not worse than one with ten Category 3 tools.
Reporting them without causing harm
Two rules keep metrics useful. First, never attach individual performance to a quality metric — the moment a person's review is measured, the metric stops measuring quality. Second, publish the denominator: "four defects post-go-live across eleven releases" is information; "four defects" is an accusation.
For management, the most persuasive pairing is defects-found-before-go-live against total validation effort. It answers the only question a CFO really has — are we spending this money on something that works — and it is the honest way to make the case for a risk-based approach. See moving from CSV to CSA.
If a metric has never once changed a decision, stop collecting it. It is costing you time and teaching your team to optimise for a number nobody uses. More on the operating side in GxP software.
Where to go next
Explore GxP Copilot for AI-native validation, TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.
